Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-14
2006-03-14
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S430000
Reexamination Certificate
active
07012090
ABSTRACT:
Substituted pyranoindoles useful for lowering and controlling IOP and glaucoma are disclosed.
REFERENCES:
patent: 4436915 (1984-03-01), Picart
patent: 4690931 (1987-09-01), Wick et al.
patent: 5151444 (1992-09-01), Ueno et al.
patent: 5296504 (1994-03-01), Stjernschantz et al.
patent: 5352708 (1994-10-01), Woodward et al.
patent: 5422368 (1995-06-01), Stjernschantz et al.
patent: 5461061 (1995-10-01), Wikstrom et al.
patent: 5494928 (1996-02-01), Bös
patent: 5571833 (1996-11-01), Kruse et al.
patent: 5633276 (1997-05-01), North et al.
patent: 5646173 (1997-07-01), Bös
patent: 5750556 (1998-05-01), Mewshaw et al.
patent: 5874477 (1999-02-01), McConnell et al.
patent: 5889052 (1999-03-01), Klimko et al.
patent: 5902815 (1999-05-01), Olney et al.
patent: 0 708 099 (2001-11-01), None
patent: WO 94/13275 (1994-06-01), None
patent: WO 98/31354 (1998-07-01), None
patent: WO 98/31354 (1998-07-01), None
patent: WO 00/12475 (2000-03-01), None
patent: WO 00/16761 (2000-03-01), None
patent: WO 00/16761 (2000-03-01), None
patent: WO 00/35922 (2000-06-01), None
Macor et al. publication, Journal of Medicinal Chemistry, 1992, 35:3625-3632.
Beresford, Isabel et al., “GR196429: A Nonindolic Agonist at High-Affinity Melatonin 1 Receptors”, J. Pharmacol. Exp. Ther. 285:1239-1245 (1998).
Bös et al., “Novel Agonists of 5HT2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder”, J. Med. Chem., vol. 40, pp 2762-2769 (1997).
Bowen et al., “Nonlinear regression using spreadsheets”, Trends in Pharmacological Sciences, 16:413 (1995.
Carvalho, C. E. and Sargent, M. V., “Naturally Occurring Dibenzofurans, Part 5.1 Synthesis of Melacarpic Acid”, J. Chem. Soc., Perkin 1:1613-1620 (1984).
Dostert, Philippe. et al., “Interactions of Monoamine Oxidase with Substrates and Inhibitors”, Medicinal Res. Rev., 9:45-89 (1989).
Fiorella, et al., “Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives”, Psychopharmacology, 121:357 (1995).
Flaugh, M. E., et al., “Synthesis and Evaluation of the Antiovulatory Activity of a Variety of Melatonin Analogues”, Journal of Medicinal Chemistry, 22:63-69 (1979).
Glennon et al., “Binding Of Benz[e]- And Benz[g]-Fused Tryptamine Derivatives At Serotonin Receptors: Evidence For A Region Of Bulk Tolerance”, Medicinal Chemistry Research, vol. 1, pp 201-206 (1991).
Glennon, R. A., et al., “Binding of Indolylalkylamines at 5-HT2 Serotonin Receptors: Examination of a Hydrophobic Binding Region”, J. Med. Chem., 33:2777-2784 (1990).
Griffin, B. W., et al., “Pharmacological Characterization of an FP Prostaglandin Receptor on Rat Vascular Smooth Muscle Cells (17r5) Coupled to Phospholnositide Turnover and Intracellular Calcium Mobilization”, J. Pharmacol. Exp. Ther., 286:411-418 (1998).
Johnson, et al., “Binding To The Serotonin 5-HT2 Receptor By The Enantiomers of 125I-DOI”, Neuropharmacology, vol. 26, No. 12, 1803-0806 (1987).
Macor, J. E., et al. “The Synthesis of Conformationally/Rotationally Restricted Analogs of the Neurotransmitter Serotonin”, Tetrahedron Lett. 35:45-48 (1994).
Macor, J. E., et al., “The Synthesis of Pyrano[3,2-e]indoles and Pyranol[2,3-f]indoles as Rotationally Restricted Phenolic Analogs of the Neurotransmitter Serotonin”, Tetrahedron, 48:1039-1052 (1992).
Macor, John E., et al., “1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-?]indole: A Rotationally Restricted Phenolic Analog of the Neurotransmitter Serotonin and Agonist Selective for Serotonin (5-HT2-Type) Receptors”, Journal Of Medicinal Chemistry, vol. 35, No. 20. pp. 3625-3632 (1992).
Parkinson, Andrews, “Biotransformation Of Xenobiotics”, Casaret & Doull's Toxicology, 5th Ed., C.D. Klassan Ed., 129-130 144-146 (1996).
Somel, M. et al., “Syntheses of (±)-Claviciptic Acid And Its Derivatives”, Heterocycles 37:719-724 (1994).
Chen Hwang-Hsing
May Jesse A.
Alcon Inc.
Copeland Barry L.
Desai Rita
Schultz Teresa J.
Shiao Robert
LandOfFree
Pyranoindoles for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyranoindoles for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyranoindoles for treating glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3571763